Cytonics ticker
WebCytonics has raised a total of $5.7M in funding over 6 rounds. Their latest funding was raised on May 18, 2024 from a Series C round. Cytonics is funded by 3 investors. SeedInvest and Rainmakers are the most recent investors. Funding Rounds. Edit Funding Rounds Section. WebApr 5, 2024 · Cytonics, with a valuation cap of $32.4 million, is raising Series C funding on SeedInvest. The company is a leader in regenerative medicine and has developed innovative therapies for musculoskeletal diseases like osteoarthritis. Cytonics has created an Autologous Platelet Integrated Concentration system that concentrates A2M from …
Cytonics ticker
Did you know?
WebCytonics Corporation, headquartered in Jupiter, FL, is a biopharmaceutical research and development Company dedicated towards engineering diagnostics and treatments for osteoarthritis. To-date, the company has … WebCytonics has received over $15M in funding to-date, including $1.8M in grants from the National Institute of Health and a $4M investment from Synthes (a Johnson and Johnson company). We are seeking to raise …
WebInvestors should take note of the following three things: One: Cytonics has a strong leader at the helm. Their founder, Dr. Gaetano Scuderi, is a former Stanford professor with over 20 years of experience as an Orthopedic … WebSep 8, 2024 · Cytonics Corporation Joey Bose President and CEO 443-827-8135 [email protected]. Virtual Investor Conferences John M. Viglotti SVP Corporate …
WebA nurse obtains small amount of blood that is drawn into a syringe. This sample then goes through a proprietary centrifugation process (Cytonics corporation) that separates and concentrates the platelets, alpha-2-macroglobulin, and other beneficial growth factors from the blood. This concentrated portion is then injected into the painful joint. WebOct 5, 2024 · According to Cytonics’ SeedInvest.com investor profile, over 27 million people in the U.S. suffer from arthritis-related pain, imposing a $180 billion burden on our health care system and economy.
WebWebsite www.cytonics.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology …
WebCytonics has already successfully commercialized a therapy for osteoarthritis. This FDA-approved medical device (the Autologous Protease Inhibitor Concentrate therapy, or “ … flutter receive_sharing_intentWebMr. Bose has over 10 years’ experience in biotechnology research development and healthcare investment banking. As President of Cytonics, his primary responsibilities include coordinating capital raising efforts, initiating clinical trials for the company’s lead drug candidate (CYT-108), filing and maintaining patent protection of intellectual property, and … greenhealthycookingyoutubeWebA high-level overview of Cyberonics, Inc. (CYBX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. flutter receive_boot_completedWebSep 8, 2024 · JUPITER, Fla., Sept. 08, 2024 (GLOBE NEWSWIRE) -- Cytonics Corporation, a biotechnology research and development company engineering novel biologic treatments for osteoarthritis and other... flutter receive_intentWebJun 12, 2024 · Cytonics is a biotechnology research and development company that specializes in developing diagnostics and therapeutics for osteoarthritis. Their flagship … greenhealthycooking.com/instant-pot-riceWebNov 5, 2024 · Cytonics is a biotech company that is focused on developing diagnostics and therapeutics for osteoarthritis. The company is also … green healthy future fromeWebWho is Cytonics Headquarters 658 W Indiantown Rd Ste 214, Jupiter, Florida, 33458, United States Phone Number (561) 406-2864 Website www.cytonics.com Revenue <$5M Industry Business Services General Business Services Cytonics's Social Media Is this data correct? View contact profiles from Cytonics Popular Searches Cytonics Cytonics Corp flutter recorder is not open